Koning Henk M, Meulen Bas C Ter
Department of Pain therapy, Pain Clinic de Bilt, Netherlands.
Department of Neurology, OLVG, Amsterdam, Netherlands.
Int Tinnitus J. 2019 Sep 4;23(2):91-96. doi: 10.5935/0946-5448.20190016.
The second cervical nerve ganglion bar appears to be beneficial in patients with treatment safe tinnitus. As far as anyone is concerned, the viability of this methodology in patients with tinnitus has never been evaluated.
The point of this investigation was to decide the adequacy of beat radiofrequency of C2 dorsal root ganglion for treating patients with tinnitus, and all the more explicitly, to survey the parameters related with a long haul advantage so as to improve understanding determination.
Subjects were 61 back to back patients who went to our facility from October 2016 to October 2018 for discussions on their tinnitus that endured for one month or more and were treated with beat radiofrequency of C2 dorsal root ganglion. Clinical information structure these patients were explored reflectively. An autonomous spectator assesses the long haul impact of the treatment by phone meet.
In a partner of patients with tinnitus that persevered for one month or more, 25% of the patients reacted with a decrease of their tinnitus after a beat radiofrequency of C2 dorsal root ganglion. The vast majority of the patients with a positive reaction appraised the impact of treatment as a decrease of half or more. At 13.5 months, half of at first effective treated patients still encountered an advantage. Unfavorable occasions of the beat radiofrequency of C2 dorsal root ganglion at 7 weeks of follow-up were an expansion of the force of the tinnitus in 7% of the patients. In patients with an age under 43 years at the time tinnitus began, 45% of them had a decrease of their tinnitus at 7 weeks following treatment with beat radiofrequency of C2 dorsal root ganglion.
Pulsed radiofrequency of C2 dorsal root ganglion can lessen the power of tinnitus extensively and for the long haul in 25% of the patients with tinnitus without genuine antagonistic impacts. We prescribe this treatment in patients with an age under 43 years at the time tinnitus began.
第二颈神经节阻滞似乎对治疗安全性耳鸣患者有益。就目前所知，该方法在耳鸣患者中的可行性从未得到评估。
本研究的目的是确定C2背根神经节的脉冲射频治疗耳鸣患者的有效性，更具体地说，是调查与长期获益相关的参数，以改善理解和决策。
研究对象为2016年10月至2018年10月连续61例因耳鸣持续1个月或更长时间而到我院就诊并接受C2背根神经节脉冲射频治疗的患者。对这些患者的临床资料进行回顾性分析。由一名独立观察者通过电话随访评估治疗的长期效果。
在一组耳鸣持续1个月或更长时间的患者中，25%的患者在接受C2背根神经节脉冲射频治疗后耳鸣减轻。大多数有阳性反应的患者将治疗效果评估为减轻一半或更多。在13.5个月时，最初接受有效治疗的患者中有一半仍有获益。随访7周时，C2背根神经节脉冲射频治疗的不良事件是7%的患者耳鸣强度增加。在耳鸣开始时年龄小于43岁的患者中，45%的患者在接受C2背根神经节脉冲射频治疗7周后耳鸣减轻。
C2背根神经节脉冲射频可在25%的耳鸣患者中显著且长期减轻耳鸣强度，且无严重不良反应。我们建议在耳鸣开始时年龄小于43岁的患者中采用这种治疗方法。
